Related Experiment Video
Updated: Jul 2, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Breast Cancer Screening in Men.
Yiming Gao1, Samantha L Heller1
1New York University-Langone, Department of Radiology, New York, NY, USA.
Early breast cancer detection significantly reduces mortality in women. For men, clinical detection is standard, but targeted mammography may improve early diagnosis and outcomes for those with risk factors.
Area of Science:
- Oncology
- Radiology
- Public Health
Background:
- Breast cancer mortality is reduced in women via screening, but men often experience delayed diagnosis and survival disparities.
- Clinical detection remains the primary method for male breast cancer, despite advances in therapy.
Purpose of the Study:
- To explore the utility of targeted mammography for male breast cancer screening.
- To examine the clinical and biologic characteristics of male breast cancer relevant to mammographic detection.
Main Methods:
- Review of existing literature on male breast cancer characteristics.
- Analysis of mammography's sensitivity and specificity in men.
- Examination of screening outcomes and risk management guidelines.
Main Results:
- Mammography is highly sensitive and specific for male breast cancer.
- Routine screening is not cost-effective due to low incidence, but targeted screening shows potential.
- Early data suggests targeted mammography may support early detection in at-risk men.
Conclusions:
- Targeted mammography could be a valuable tool for early detection of male breast cancer in specific populations.
- Further research is needed to optimize risk stratification and screening protocols for men.
- Updates in risk management guidelines are crucial for improving outcomes.
More Related Videos
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018